Cleveland Clinic R.J. Fasenmyer Center for Clinicial Immunology in conjunction with Cleveland Society of Rheumatology and
Phoenix Rheumatology Association
Advances in B Cell Science: Clinician Update
A Report from the Annual National Rheumatology Meeting
A complimentary symposium offered in two locations.
Meeting Location 1: 1:00 pm – 5:00 pm Event registration for Feb. 3 is now CLOSED. |
Meeting Location 2: 8:00 am – 12:00 pm |
Both events are complimentary
Description
In recent years, our understanding of autoimmune rheumatic diseases (ARDs) has led to encouraging advances in treatment. The use of targeted biologic therapy is on the rise as further data emerge regarding their efficacy, utility, and safety, eliminating reliance on therapies that affect a wide range of cellular targets. The increasing adoption of these targeted biologic agents into clinical practice challenges clinicians to remain informed and up to date regarding new data released at national annual conferences. This symposium is designed for busy clinicians who are interested in keeping abreast of cutting-edge data regarding novel therapies for ARDs. Expert faculty will bridge the gap between the current immunobiologic data and the day-to-day workings of clinical practice.
GOING GREENElectronic Syllabus: Syllabus will only be provided to registrants on a USB flash drive. Attendees are encouraged to bring their laptops to the symposium to view the syllabus. |
Target Audience
This educational activity is intended for rheumatologists, immunologists, clinical researchers, and allied health care professionals who care for patients with autoimmune rheumatic diseases.
Objectives
- Review advances in molecular biology that contribute to the understanding of B-cell biology, the integrated immune response, and the pathogenesis/clinical features of autoimmune rheumatic diseases;
- Summarize recently published clinical data relating to the usage of B-cell-directed therapies for rheumatoid arthritis;
- Examine current approaches and clinical methodology to the usage of B-cell-directed therapeutics in autoimmune rheumatic diseases;
- Describe recent results of clinical trials of B-cell-directed therapies in SLE and ANCA-associated vasculitis;
- Assess the impact of biologic agents on the rates of serious infections, humoral immunity, and vaccine response.
Director
| Leonard Calabrese, DO Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Vice Chairman, Department of Rheumatic and Immunologic Diseases R.J. Fasenmyer Chair of Clinical Immunology Orthopaedics & Rheumatologic Institute Cleveland Clinic Cleveland, Ohio |
Faculty
| Marc D. Cohen, MD Professor of Medicine National Jewish Medical and Research Center Denver, Colorado |
| Richard Furie, MD Chief, Division of Rheumatology and Allergy-Clinical Immunology North Shore-Long Island Jewish Health System Professor of Medicine Hofstra University School of Medicine Albert Einstein College of Medicine Lake Success, New York |
| Jonathan Kay, MD Director of Clinical Research Rheumatology Division Professor of Medicine University of Massachusetts Medical School Worchester, Massachusetts |
| Gregg J. Silverman, MD Professor of Medicine Director, Laboratory of B-Cell Immunology Division of Rheumatology, Allergy, and Immunology University of California San Diego School of Medicine La Jolla, California |
Agenda
| WEDNESDAY, FEBRUARY 3, 2010 12:00 PM - 5:00 PM Cleveland, OH |
SATURDAY, FEBRUARY 13, 2010 7:00 AM - 12:00 PM Scottsdale, AZ |
| Moderator: Leonard Calabrese, DO |
Moderator: Leonard Calabrese, DO |
| 12:00 pm Registration | 7:00 am Registration |
| 1:00 pm Welcoming Remarks | 8:00 am Welcoming Remarks |
| DOWNLOAD CLEVELAND AGENDA |
DOWNLOAD SCOTTSDALE AGENDA |
Topics |
|
| Pathogenesis of Rheumatoid Arthritis: Are There Two Distinct Diseases? | Gregg Silverman, MD |
| B-Cell–Directed Therapies in Rheumatoid Arthritis | Marc Cohen, MD |
| Current Status of Second-Line Therapy of Biologics Roundtable Discussion | Leonard Calabrese, DO Marc Cohen, MD Jonathan Kay, MD Gregg Silverman, MD |
| Rituximab and Chronic Viral Infection | Leonard Calabrese, DO |
| B Cells, Cytokines, and SLE | Jonathan Kay, MD (Cleveland) Richard Furie, MD (Arizona) |
| Evolution of Biologic Therapy for Systemic Vasculitis | Leonard Calabrese, DO |
| Panel Discussion & Questions | |
Location
| February 3, 2010 Cleveland Clinic Lerner Institute 5th Floor, NA J-08 Amphitheater 9500 Euclid Avenue Cleveland, Ohio |
February 13, 2010 Fairmont Scottsdale 7575 East Princess Drive Scottsdale, Arizona
|
| Click here for directions | Click here for the Google Map location |
Additional Information
For further information about this symposium, contact UNITECH Communications® at:
Local: 216-448-0770
Toll Free: 800-238-6750
For questions about registering online, call 216-448-0777 or email CMEregistration@ccf.org.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.
Americans with Disabilities Act
The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify UNITECH Communications® at 216-448-0770 or 800-238-6750 at least two weeks prior to the activity.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Online Registration/Fees
| Category | Event Fees |
|---|---|
| All Attendees | Complimentary |
| Cleveland
Event Registration Feb. 3, 2010 |
Scottsdale Event Registration Feb. 13, 2010 |
|---|---|
|
SCOTTSDALE REGISTRATION BUTTON  |
